The University of Chicago Header Logo

Connection

Anita S. Chong to Humans

This is a "connection" page, showing publications Anita S. Chong has written about Humans.
Connection Strength

1.128
  1. MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection. Transplantation. 2023 Dec 01; 107(12):2526-2532.
    View in: PubMed
    Score: 0.032
  2. A novel triptolide analog downregulates NF-?B and induces mitochondrial apoptosis pathways in human pancreatic cancer. Elife. 2023 Oct 25; 12.
    View in: PubMed
    Score: 0.031
  3. A transitional B-cell cytokine biomarker for risk stratifying renal transplant patients with borderline rejection. Kidney Int. 2023 04; 103(4):658-660.
    View in: PubMed
    Score: 0.030
  4. Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection. Transplantation. 2023 01 01; 107(1):98-104.
    View in: PubMed
    Score: 0.029
  5. Sugar-coated Antigens Generated During Pregnancy Mediate Fetomaternal Tolerance. Transplantation. 2022 11 01; 106(11):2099-2100.
    View in: PubMed
    Score: 0.029
  6. A multi-faceted approach to sex and gender equity in solid organ transplantation: The Women in Transplantation Initiative of The Transplantation Society. Front Immunol. 2022; 13:1006855.
    View in: PubMed
    Score: 0.029
  7. From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant. 2022 10 01; 27(5):376-384.
    View in: PubMed
    Score: 0.029
  8. Semiallogeneic Pregnancy: A Paradigm Change for T-cell Transplantation Tolerance. Transplantation. 2022 06 01; 106(6):1098-1100.
    View in: PubMed
    Score: 0.028
  9. Toward an understanding of allogeneic conflict in pregnancy and transplantation. J Exp Med. 2022 05 02; 219(5).
    View in: PubMed
    Score: 0.028
  10. The First ITS Meeting. Transplantation. 2020 06; 104(6):1114-1116.
    View in: PubMed
    Score: 0.025
  11. Mechanisms of organ transplant injury mediated by B cells and antibodies: Implications for antibody-mediated rejection. Am J Transplant. 2020 06; 20 Suppl 4:23-32.
    View in: PubMed
    Score: 0.025
  12. B cells as antigen-presenting cells in transplantation rejection and tolerance. Cell Immunol. 2020 03; 349:104061.
    View in: PubMed
    Score: 0.024
  13. Desensitization in the Era of Precision Medicine: Moving From the Bench to Bedside. Transplantation. 2019 08; 103(8):1574-1581.
    View in: PubMed
    Score: 0.023
  14. B Cell Recruitment Follows Kidney Injury and Maladaptive Repair. Transplantation. 2019 08; 103(8):1527-1529.
    View in: PubMed
    Score: 0.023
  15. Outstanding questions in transplantation: B cells, alloantibodies, and humoral rejection. Am J Transplant. 2019 08; 19(8):2155-2163.
    View in: PubMed
    Score: 0.023
  16. New insights into the development of B cell responses: Implications for solid organ transplantation. Hum Immunol. 2019 Jun; 80(6):378-384.
    View in: PubMed
    Score: 0.022
  17. Heterogeneity of memory B cells. Am J Transplant. 2018 04; 18(4):779-784.
    View in: PubMed
    Score: 0.021
  18. Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
    View in: PubMed
    Score: 0.021
  19. Alone Again, Naturally: B Cells Encountering Antigen Without T cells. Transplantation. 2017 09; 101(9):1956-1958.
    View in: PubMed
    Score: 0.020
  20. Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
    View in: PubMed
    Score: 0.020
  21. Transplantation tolerance after allograft rejection. Curr Opin Organ Transplant. 2017 Feb; 22(1):64-70.
    View in: PubMed
    Score: 0.020
  22. From Pipe Dream to Donor-Specific PC Elimination: Novel Ways to Target Alloantibodies. Transplantation. 2016 11; 100(11):2238-2239.
    View in: PubMed
    Score: 0.019
  23. Establishment of a global virtual laboratory for transplantation: a symposium report. Transplantation. 2015 Feb; 99(2):381-4.
    View in: PubMed
    Score: 0.017
  24. Memory B cells in transplantation. Transplantation. 2015 Jan; 99(1):21-8.
    View in: PubMed
    Score: 0.017
  25. Transplantation: molecular phenotyping of T-cell-mediated rejection. Nat Rev Nephrol. 2014 12; 10(12):678-80.
    View in: PubMed
    Score: 0.017
  26. New kid on the pretransplant block: IgG recognizing apoptotic cells. Am J Transplant. 2014 Jul; 14(7):1477-8.
    View in: PubMed
    Score: 0.016
  27. Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs. Adv Healthc Mater. 2014 Nov; 3(11):1898-908.
    View in: PubMed
    Score: 0.016
  28. Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipients. Transplantation. 2014 Apr 27; 97(8):846-53.
    View in: PubMed
    Score: 0.016
  29. Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev. 2014 Mar; 258(1):80-101.
    View in: PubMed
    Score: 0.016
  30. Microbes and allogeneic transplantation. Transplantation. 2014 Jan 15; 97(1):5-11.
    View in: PubMed
    Score: 0.016
  31. Plasma cell densities and glomerular filtration rates predict renal allograft outcomes following acute rejection. Transpl Int. 2012 Oct; 25(10):1050-8.
    View in: PubMed
    Score: 0.014
  32. The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol. 2012 May 25; 12(6):459-71.
    View in: PubMed
    Score: 0.014
  33. Three Strikes and You're Cured. Sci Transl Med. 2012 May 09; 4(133):133fs12.
    View in: PubMed
    Score: 0.014
  34. "Tip-toeing" to an assay for transplantation tolerance? Am J Transplant. 2012 Mar; 12(3):519-20.
    View in: PubMed
    Score: 0.014
  35. Matchmaking the B-cell signature of tolerance to regulatory B cells. Am J Transplant. 2011 Dec; 11(12):2555-60.
    View in: PubMed
    Score: 0.014
  36. Experimental models of B cell tolerance in transplantation. Semin Immunol. 2012 Apr; 24(2):77-85.
    View in: PubMed
    Score: 0.014
  37. Making a B-line for transplantation tolerance. Am J Transplant. 2011 Mar; 11(3):420-1.
    View in: PubMed
    Score: 0.013
  38. Bacterial infections, alloimmunity, and transplantation tolerance. Transplant Rev (Orlando). 2011 Jan; 25(1):27-35.
    View in: PubMed
    Score: 0.013
  39. Toll-like receptors (TLRs) in transplantation. Front Biosci (Elite Ed). 2009 06 01; 1(1):36-43.
    View in: PubMed
    Score: 0.012
  40. Antagonistic effect of toll-like receptor signaling and bacterial infections on transplantation tolerance. Transplantation. 2009 May 15; 87(9 Suppl):S77-9.
    View in: PubMed
    Score: 0.012
  41. Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant. 2008 Aug; 13(4):358-65.
    View in: PubMed
    Score: 0.011
  42. Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol. 2008 May 01; 180(9):5991-9.
    View in: PubMed
    Score: 0.011
  43. Cellular therapies for type 1 diabetes. Horm Metab Res. 2008 Feb; 40(2):147-54.
    View in: PubMed
    Score: 0.011
  44. State-of-the-art Meeting on Sex and Gender in Transplantation: The Female Perspective. Transplantation. 2023 09 01; 107(9):1865-1869.
    View in: PubMed
    Score: 0.008
  45. Sex as a biological variable: Mechanistic insights and clinical relevance in solid organ transplantation. Am J Transplant. 2023 11; 23(11):1661-1672.
    View in: PubMed
    Score: 0.008
  46. Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism. Am J Transplant. 2023 08; 23(8):1116-1129.
    View in: PubMed
    Score: 0.008
  47. The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol. 2003 Feb 01; 170(3):1531-9.
    View in: PubMed
    Score: 0.007
  48. Navigating the Dobbs versus Jackson America for Patients with CKD and Kidney Transplants. J Am Soc Nephrol. 2023 02 01; 34(2):201-204.
    View in: PubMed
    Score: 0.007
  49. Joining Forces in Basic Science: ITS Meeting 2.0. Transpl Int. 2022; 35:10843.
    View in: PubMed
    Score: 0.007
  50. Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants. J Clin Invest. 2022 09 01; 132(17).
    View in: PubMed
    Score: 0.007
  51. The Women of FOCIS: Promoting Equality and Inclusiveness in a Professional Federation of Clinical Immunology Societies. Front Immunol. 2022; 13:816535.
    View in: PubMed
    Score: 0.007
  52. Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection. J Infect Dis. 2022 01 05; 225(1):177-185.
    View in: PubMed
    Score: 0.007
  53. Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection. Nat Commun. 2021 07 16; 12(1):4372.
    View in: PubMed
    Score: 0.007
  54. Sex matters: COVID-19 in kidney transplantation. Kidney Int. 2021 03; 99(3):555-558.
    View in: PubMed
    Score: 0.006
  55. A taste of honey. J Paediatr Child Health. 2000 Dec; 36(6):596-7.
    View in: PubMed
    Score: 0.006
  56. The Impact of COVID-19 on the State of Clinical and Laboratory Research Globally in Transplantation in May 2020. Transplantation. 2020 11; 104(11):2252-2257.
    View in: PubMed
    Score: 0.006
  57. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol. 2000 Jun; 8(2):129-37.
    View in: PubMed
    Score: 0.006
  58. Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group. Transplantation. 2020 05; 104(5):911-922.
    View in: PubMed
    Score: 0.006
  59. Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients. Am J Transplant. 2020 10; 20(10):2675-2685.
    View in: PubMed
    Score: 0.006
  60. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide. Transplantation. 1999 Sep 27; 68(6):814-25.
    View in: PubMed
    Score: 0.006
  61. In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
    View in: PubMed
    Score: 0.006
  62. The pursuit of transplantation tolerance: new mechanistic insights. Cell Mol Immunol. 2019 04; 16(4):324-333.
    View in: PubMed
    Score: 0.006
  63. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999; 42(5-6):412-8.
    View in: PubMed
    Score: 0.006
  64. An optimized protocol to quantify signaling in human transitional B cells by phospho flow cytometry. J Immunol Methods. 2018 12; 463:112-121.
    View in: PubMed
    Score: 0.006
  65. Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and Tolerance. Cell Rep. 2018 08 21; 24(8):2112-2126.
    View in: PubMed
    Score: 0.005
  66. IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Cancer Res. 1998 Jul 01; 58(13):2832-7.
    View in: PubMed
    Score: 0.005
  67. The IRF4 Gene Regulatory Module Functions as a Read-Write Integrator to Dynamically Coordinate TĀ Helper Cell Fate. Immunity. 2017 09 19; 47(3):481-497.e7.
    View in: PubMed
    Score: 0.005
  68. Self-Antigen-Driven Thymic B Cell Class Switching Promotes T Cell Central Tolerance. Cell Rep. 2016 10 04; 17(2):387-398.
    View in: PubMed
    Score: 0.005
  69. Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans. J Immunol. 2016 08 15; 197(4):1118-26.
    View in: PubMed
    Score: 0.005
  70. Receptors that turn on and turn off natural killer cells. J Heart Lung Transplant. 1996 Jul; 15(7):675-83.
    View in: PubMed
    Score: 0.005
  71. Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro. Transplantation. 1996 Jan 15; 61(1):140-5.
    View in: PubMed
    Score: 0.005
  72. Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem. 1995 May 26; 270(21):12398-403.
    View in: PubMed
    Score: 0.004
  73. The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant. 2015 Feb; 20(1):1-7.
    View in: PubMed
    Score: 0.004
  74. CD45-cross-linking stimulates IFN-gamma production in NK cells. J Immunol. 1995 Jan 15; 154(2):644-52.
    View in: PubMed
    Score: 0.004
  75. Gut microbiota elicits a protective immune response against malaria transmission. Cell. 2014 Dec 04; 159(6):1277-89.
    View in: PubMed
    Score: 0.004
  76. CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell Immunol. 1994 Aug; 157(1):92-105.
    View in: PubMed
    Score: 0.004
  77. ICAM-1 and LFA-3 enhance the ability of anti-CD3 mAb to stimulate interferon gamma production in interleukin-2-activated T cells. Cancer Immunol Immunother. 1994 Aug; 39(2):127-34.
    View in: PubMed
    Score: 0.004
  78. Mechanisms and consequences of injury and repair in older organ transplants. Transplantation. 2014 Jun 15; 97(11):1091-9.
    View in: PubMed
    Score: 0.004
  79. Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations. J Neuroimmunol. 2014 Jul 15; 272(1-2):67-75.
    View in: PubMed
    Score: 0.004
  80. AST Cutting Edge of Transplantation 2013 Meeting Report: a comprehensive look at B cells and antibodies in transplantation. Am J Transplant. 2014 Mar; 14(3):524-30.
    View in: PubMed
    Score: 0.004
  81. Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation. Transplantation. 1993 Jun; 55(6):1361-6.
    View in: PubMed
    Score: 0.004
  82. Leflunomide, a novel immunomodulatory agent: in vitro analyses of the mechanism of immunosuppression. Transplant Proc. 1993 Feb; 25(1 Pt 1):747-9.
    View in: PubMed
    Score: 0.004
  83. Diverse multidrug-resistance-modification agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother. 1993; 36(2):133-9.
    View in: PubMed
    Score: 0.004
  84. Stimulation of IFN-gamma, TNF-alpha, and TNF-beta secretion in IL-2-activated T cells: costimulatory roles for LFA-1, LFA-2, CD44, and CD45 molecules. Cell Immunol. 1992 Oct 01; 144(1):69-79.
    View in: PubMed
    Score: 0.004
  85. Monoclonal antibodies anti-CD3, anti-TCR alpha beta and anti-CD2 act synergistically with tumor cells to stimulate lymphokine-activated killer cells and tumor-infiltrating lymphocytes to secrete interferon gamma. Cancer Immunol Immunother. 1992; 35(5):335-41.
    View in: PubMed
    Score: 0.003
  86. Ability of cell-sized beads bearing tumor cell membrane proteins to stimulate LAK cells to secrete interferon-gamma and tumor necrosis factor-alpha. Cell Immunol. 1991 Apr 15; 134(1):96-110.
    View in: PubMed
    Score: 0.003
  87. Gamma-irradiated peripheral blood mononuclear cells can express LAK activity. Int J Cell Cloning. 1991 Jan; 9(1):65-77.
    View in: PubMed
    Score: 0.003
  88. Regulation of tumor necrosis factor secretion in leukocytes from alpha-1-antitrypsin deficient humans. Immunol Invest. 1990 Oct-Dec; 19(5-6):453-61.
    View in: PubMed
    Score: 0.003
  89. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation. 2010 Sep 15; 90(5):540-6.
    View in: PubMed
    Score: 0.003
  90. Phenotypic analyses of lymphokine-activated killer cells that release interferon gamma and tumor necrosis factor alpha. Cancer Immunol Immunother. 1990; 31(4):255-9.
    View in: PubMed
    Score: 0.003
  91. Tumor targets stimulate IL-2 activated killer cells to produce interferon-gamma and tumor necrosis factor. J Immunol. 1989 Mar 15; 142(6):2133-9.
    View in: PubMed
    Score: 0.003
  92. Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets. Cancer Immunol Immunother. 1989; 29(4):270-8.
    View in: PubMed
    Score: 0.003
  93. Blocking of lymphokine activated killer (LAK) cell mediated cytotoxicity by cell-sized beads bearing tumor cell proteins. J Immunol. 1988 Dec 15; 141(12):4418-24.
    View in: PubMed
    Score: 0.003
  94. The multiple facets of toll-like receptors in transplantation biology. Transplantation. 2008 Jul 15; 86(1):1-9.
    View in: PubMed
    Score: 0.003
  95. American society of transplantation symposium on B cells in transplantation: harnessing humoral immunity from rodent models to clinical practice. Am J Transplant. 2007 Jun; 7(6):1464-70.
    View in: PubMed
    Score: 0.003
  96. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
    View in: PubMed
    Score: 0.002
  97. Direct killing of xenograft cells by CD8+ T cells of discordant xenograft recipients. Transplantation. 2002 Dec 15; 74(11):1587-95.
    View in: PubMed
    Score: 0.002
  98. Experiences with leflunomide in solid organ transplantation. Transplantation. 2002 Feb 15; 73(3):358-66.
    View in: PubMed
    Score: 0.002
  99. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation. 2001 Jan 15; 71(1):170-4.
    View in: PubMed
    Score: 0.002
  100. Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation. Transplant Proc. 2000 Aug; 32(5):991-3.
    View in: PubMed
    Score: 0.002
  101. Transcriptional regulation of Fas gene expression by GA-binding protein and AP-1 in T cell antigen receptor.CD3 complex-stimulated T cells. J Biol Chem. 1999 Dec 03; 274(49):35203-10.
    View in: PubMed
    Score: 0.001
  102. Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Neurodegeneration. 1996 Mar; 5(1):1-11.
    View in: PubMed
    Score: 0.001
  103. Evidence for a dithiol-activated signaling pathway in natural killer cell avidity regulation of leukocyte function antigen-1: structural requirements and relationship to phorbol ester- and CD16-triggered pathways. Blood. 1995 Sep 15; 86(6):2288-301.
    View in: PubMed
    Score: 0.001
  104. Splanchnic transplantation. Transplant Proc. 1994 Jun; 26(3):1411-2.
    View in: PubMed
    Score: 0.001
  105. Natural killer cell cytotoxicity and the multidrug resistance gene. Transplant Proc. 1993 Feb; 25(1 Pt 1):96-7.
    View in: PubMed
    Score: 0.001
  106. Daily determinations of serum lymphotoxin allows for accurate early diagnosis of hepatic allograft rejection. Transplant Proc. 1993 Feb; 25(1 Pt 2):928-30.
    View in: PubMed
    Score: 0.001
  107. T cell immunodeficiency in dyskeratosis congenita. Arch Dis Child. 1992 Apr; 67(4):524-6.
    View in: PubMed
    Score: 0.001
  108. Multidrug resistance activity in human lymphocytes. Hum Immunol. 1991 Oct; 32(2):134-40.
    View in: PubMed
    Score: 0.001
  109. Modification of the clonogenic assay for the detection of lymphokine activated killer cell activity. J Immunol Methods. 1990 Mar 27; 128(1):119-26.
    View in: PubMed
    Score: 0.001
  110. Cytostatic and cytotoxic activity of lymphokine-activated killer cell supernatants. Cancer Immunol Immunother. 1989; 30(1):65-70.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.